Plecanatide 3 MG Oral Tablet [Trulance] — RxCUI 1873765
RxNorm drug concept · Semantic branded drug
RxCUI 1873765
Semantic branded drug · SBD
● Current RxNorm concept 1 FDA product
4 package NDCs
Snapshot Jul 14, 2026
What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.
🗂️ Key Facts
RxCUI1873765
Official namePlecanatide 3 MG Oral Tablet [Trulance]
Concept typeSemantic branded drug (SBD)
RxNorm statusCurrent RxNorm concept
Also known asTrulance 3 MG Oral Tablet
FDA products mapped1
Package NDCs mapped4
Reported Medicaid activity (SDUD)44,504 prescriptions · 48 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026
📖 Skip the Codes — Read It in Plain English.
Our pharmacist-built guide to Plecanatide: what it is, how it’s used, side effects, and interactions.
📗 Our plain-language guide HelloPharmacist
- Trulance is designed to relieve constipation — whether you have chronic idiopathic constipation (ongoing constipation with no clear cause) or irritable bowel syndrome with constipa...
- What is Trulance actually supposed to do for me?
- Trulance can be taken with or without food — that's flexible. Just be aware that taking it with a meal, especially a high-fat one, may lead to looser stools than taking it fasted....
- Does it matter if I take Trulance with food or on an empty stomach?
🕸️ Concept Web — How Plecanatide 3 MG Oral Tablet [Trulance] Connects
One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept
Plecanatide 3 MG Oral Tablet [Trulance]
RxCUI 1873765 Semantic branded drug · SBD
Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.
-
Ingredients 1
The active substance itself — no strength, form, or brand attached yet.
-
Plecanatide
1873752IN
-
Plecanatide
-
Brand names 1
The same medicine's trade names. A brand name alone says nothing about strength or form.
-
Trulance
1873760BN
-
Trulance
-
Dose forms 9
The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
-
Plecanatide Oral Tablet
1873756SCDF -
Plecanatide Oral Product
1873754SCDG -
Plecanatide Pill
1873755SCDG -
Plecanatide Oral Tablet [Trulance]
1873762SBDF -
Trulance Oral Product
1873763SBDG -
Trulance Pill
1873764SBDG -
Oral Tablet
317541DF -
Oral Product
1151131DFG - +1 more in this family
-
Plecanatide Oral Tablet
-
Clinical & branded drugs 3
Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
-
Plecanatide 3 MG Oral Tablet
1873757SCD -
Plecanatide 3 MG
1873753SCDC -
Plecanatide 3 MG [Trulance]
1873761SBDC
-
Plecanatide 3 MG Oral Tablet
Showing up to 8 concepts per family — 13 of 14 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.
🔀 Generic ⇄ Brand Crosswalk
The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.
Generic (Clinical) Concepts
-
Plecanatide 3 MG Oral Tablet
SCD · 1873757 -
Plecanatide 3 MG
SCDC · 1873753 -
Plecanatide Oral Tablet
SCDF · 1873756 -
Plecanatide Oral Product
SCDG · 1873754 -
Plecanatide Pill
SCDG · 1873755
Brand-Name Concepts
-
Plecanatide 3 MG [Trulance]
SBDC · 1873761 -
Plecanatide Oral Tablet [Trulance]
SBDF · 1873762 -
Trulance Oral Product
SBDG · 1873763 -
Trulance Pill
SBDG · 1873764 -
Trulance
BN · 1873760
📦 FDA Products & Package NDCs
1 product · 4 package NDCs
4 package NDCs map to RxCUI 1873765 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
| Package NDC | Package | Brand / generic name | Labeler | Marketing start |
|---|---|---|---|---|
| 65649-0003-01 | 1 BOTTLE in 1 CARTON (65649-003-01) / 1 TABLET in 1 BOTTLE | Trulance Immediate release | Salix Pharmaceuticals Inc. | 2017-02-21 |
| 65649-0003-03 | 1 BOTTLE in 1 CARTON (65649-003-03) / 3 TABLET in 1 BOTTLE | Trulance Immediate release | Salix Pharmaceuticals Inc. | 2017-02-21 |
| 65649-0003-07 | 1 BOTTLE in 1 CARTON (65649-003-07) / 7 TABLET in 1 BOTTLE | Trulance Immediate release | Salix Pharmaceuticals Inc. | 2017-02-21 |
| 65649-0003-30 | 30 TABLET in 1 BOTTLE (65649-003-30) | Trulance Immediate release | Salix Pharmaceuticals Inc. | 2017-02-21 |
Observed labelers:
Salix Pharmaceuticals Inc. (4)
— this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.
🗃️ Sources & Limits
Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
- A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
- Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
- Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
- Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.
Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.